期刊
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY
卷 17, 期 2, 页码 126-130出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MED.0b013e3283372819
关键词
innate immunity; toll-like receptors; type 1 diabetes
资金
- National Institutes of Health [DK32520]
- Beta Cell Biology Consortium
- Juvenile Diabetes Research Foundation
- Brehm Foundation, International
- Helmsley Foundation
Purpose of review Type 1 diabetes (T1D) is an autoimmune disease typically believed to result from malfunctions in adaptive immune response signaling which result in activation of self-reactive T cells. However, recent research has indicated components of the innate immune response as having a key role in the initiation of the autoimmune process of T1D. This review will highlight recent studies which examined the role of innate immune response signaling and the connections to T1D pathogenesis. Recent findings Investigations indicate that components of innate immunity, including inflammation and Toll-like receptor signaling, are involved in pancreatic islet infiltration and insulitis. Recent studies examining the role of viral infections in T1D development also implicate innate immune response signaling in disease pathogenesis. Summary Current research indicates that components of innate immune response signaling are involved in the initiation of the autoimmune process which results in the eventual destruction of beta cells during T1D pathogenesis. Continuing efforts by researchers to uncover the molecular pathways of innate immunity linked to T1D development could potentially lead to therapeutics capable of preventing and curing the autoimmune disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据